#USA #Bloomington #Mytulin EQ #Gerosynth Labs #horse health

Gerosynth Labs Launches Mytulin EQ: A New Standard in Equine Nutrition

In a significant advancement within the veterinary health sector, Gerosynth Labs, Inc., a private biotechnology firm, has introduced Mytulin EQ, a cutting-edge nutritional supplement designed specifically for horses. This product is crafted to promote immune health, support cellular vitality, and enhance performance recovery, showcasing a fusion of innovative biotechnology and animal health.

What is Mytulin EQ?

Mytulin EQ is the result of years of rigorous translational research, focusing on the intersection of biotechnology and equine care. The company's CEO, Alisha O'Dell, emphasized that the primary goal is to offer evidence-based, naturally derived solutions that elevate equine wellness beyond the constraints of traditional pharmaceuticals.

Developed through proprietary phytochemical research, Mytulin EQ notably enhances musculoskeletal strength, maintains gastrointestinal balance, and rejuvenates mitochondrial function. These factors are crucial for optimizing the health and longevity of horses, making it a valuable addition to equine care regimens.

Nature’s Power Behind the Formula

What sets Mytulin EQ apart is its unique formulation derived from wild-harvested chaga mushrooms sourced from Alaska’s Arctic Circle. This extreme climate is conducive to producing nutrient-rich mushrooms, and combined with Gerosynth's innovative manufacturing techniques, these ingredients yield a highly bioactive composition.

The bioactive elements of Mytulin EQ provide a potent foundation for equine cellular support and enhance performance capabilities. As Dr. Kendall Willson, a distinguished veterinarian, pointed out, horses competing at high levels require exceptional cellular recovery and robust immune resilience. Mytulin EQ effectively addresses these needs, giving veterinarians and trainers a valuable new ally in sustaining equine health.

Pricing and Availability

Mytulin EQ is currently available on the official website, mytosynth.com, in single 64 oz. pouches priced at $280. Additionally, customers can purchase a pack of three 64 oz. pouches for $540. To encourage trial, a limited-time introductory offer is available throughout November, allowing customers to purchase a single pouch for just $220.

About Gerosynth Labs

Gerosynth Labs, Inc. is committed to advancing innovative solutions in oncology and cellular health, operating through a robust research and development platform. The firm specializes in designing both pharmaceutical and nutraceutical formulations aimed at bolstering immune function, longevity, and metabolic resilience. As the parent company of Mytosynth Nutraceuticals, LLC, it aims to bridge biotechnological discoveries with real-world applications in both human and animal health. The company is headquartered in Bloomington, Minnesota, and continues to be a pioneer in equine and veterinary health advancements.

In conclusion, the launch of Mytulin EQ marks a pivotal moment in the ongoing evolution of equine nutrition, providing a natural, scientifically-backed option that meets the growing demands of horse health and performance management. As equine health continues to evolve, products like Mytulin EQ represent the future of animal care, combining natural ingredients with cutting-edge science to foster optimal well-being.